Company Filing History:
Years Active: 2024
Title: Liwei Liu - Innovator in Cancer Research
Introduction
Liwei Liu is a prominent inventor based in Guiyang, China. He has made significant contributions to the field of cancer research through his innovative inventions. His work focuses on developing compounds that exhibit better inhibitory activity on cancer cells.
Latest Patents
Liwei Liu holds a patent for a compound titled "4-(N-methyl) aminopiperidine myricetin derivative containing dithiocarbamate, preparation method and application." This invention discloses a derivative that has shown promising results in inhibiting cancer cell growth. The structural general formula of the compound includes various substituents that enhance its efficacy against cancer cells.
Career Highlights
Liwei Liu is affiliated with Guizhou University, where he conducts research and develops new compounds. His work has garnered attention for its potential applications in cancer treatment. Liu's dedication to research and innovation has positioned him as a key figure in his field.
Collaborations
Liwei Liu collaborates with notable colleagues, including Wei Xue and Shichun Jiang. These partnerships enhance the research efforts and contribute to the advancement of cancer treatment methodologies.
Conclusion
Liwei Liu's innovative work in developing cancer-inhibiting compounds highlights his significant role in the scientific community. His contributions are paving the way for new therapeutic options in cancer treatment.